Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1954 1
1955 1
1979 1
1980 8
1981 9
1982 6
1983 8
1984 7
1985 13
1986 11
1987 15
1988 10
1989 13
1990 13
1991 26
1992 16
1993 29
1994 25
1995 37
1996 35
1997 47
1998 40
1999 45
2000 65
2001 66
2002 74
2003 106
2004 128
2005 156
2006 160
2007 163
2008 183
2009 228
2010 222
2011 272
2012 314
2013 392
2014 502
2015 554
2016 577
2017 649
2018 708
2019 829
2020 1000
2021 226
Text availability
Article attribute
Article type
Publication date

Search Results

7,199 results
Results by year
Filters applied: . Clear all
Page 1
A materials-science perspective on tackling COVID-19.
Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. Tang Z, et al. Nat Rev Mater. 2020 Oct 14:1-14. doi: 10.1038/s41578-020-00247-y. Online ahead of print. Nat Rev Mater. 2020. PMID: 33078077 Free PMC article. Review.
Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancer.
Vykoukal J, Fahrmann JF, Gregg JR, Tang Z, Basourakos S, Irajizad E, Park S, Yang G, Creighton CJ, Fleury A, Mayo J, Paulucci-Holthauzen A, Dennison JB, Murage E, Peterson CB, Davis JW, Kim J, Hanash S, Thompson TC. Vykoukal J, et al. Among authors: tang z. Nat Commun. 2020 Aug 27;11(1):4279. doi: 10.1038/s41467-020-17645-z. Nat Commun. 2020. PMID: 32855410 Free PMC article.
Emerging Chiral Materials.
Kuang H, Xu C, Tang Z. Kuang H, et al. Among authors: tang z. Adv Mater. 2020 Oct;32(41):e2005110. doi: 10.1002/adma.202005110. Adv Mater. 2020. PMID: 33463787 No abstract available.
Authors' response.
Li X, Xu J, Yin Y, Liu T, Chang L, Tang Z, Chen S. Li X, et al. Among authors: tang z. Am J Orthod Dentofacial Orthop. 2020 Oct;158(4):473. doi: 10.1016/j.ajodo.2020.06.020. Am J Orthod Dentofacial Orthop. 2020. PMID: 32988562 No abstract available.
Pamiparib is a potent and selective PARP inhibitor with unique potential for the treatment of brain tumor.
Xiong Y, Guo Y, Liu Y, Wang H, Gong W, Liu Y, Wang X, Gao Y, Yu F, Su D, Wang F, Zhu Y, Zhao Y, Wu Y, Qin Z, Sun X, Ren B, Jiang B, Jin W, Shen Z, Tang Z, Song X, Wang L, Liu X, Zhou C, Jiang B. Xiong Y, et al. Among authors: tang z. Neoplasia. 2020 Sep;22(9):431-440. doi: 10.1016/j.neo.2020.06.009. Epub 2020 Jul 8. Neoplasia. 2020. PMID: 32652442 Free PMC article.
Biallelic Intronic AAGGG Expansion of RFC1 is Related to Multiple System Atrophy.
Wan L, Chen Z, Wan N, Liu M, Xue J, Chen H, Zhang Y, Peng Y, Tang Z, Gong Y, Yuan H, Wang S, Deng Q, Hou X, Wang C, Peng H, Shi Y, Peng L, Lei L, Duan R, Xia K, Qiu R, Shen L, Tang B, Ashizawa T, Jiang H. Wan L, et al. Among authors: tang z. Ann Neurol. 2020 Dec;88(6):1132-1143. doi: 10.1002/ana.25902. Epub 2020 Oct 3. Ann Neurol. 2020. PMID: 32939785
IL-6 trans-signaling promotes the expansion and anti-tumor activity of CAR T cells.
Jiang Z, Liao R, Lv J, Li S, Zheng D, Qin L, Wu D, Chen S, Long Y, Wu Q, Wang S, Lin S, Huang X, Tang Z, Shi P, Zhou H, Liu Q, Zhao R, Li Y, Jie Y, Wei W, Lai P, Du X, Cui S, Weinkove R, Liu P, Pei D, Yao Y, Li P. Jiang Z, et al. Among authors: tang z. Leukemia. 2020 Nov 9. doi: 10.1038/s41375-020-01085-1. Online ahead of print. Leukemia. 2020. PMID: 33168950
7,199 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page